Activation_NN
of_IN
transcription_NN
by_IN
binding_NN
of_IN
NF-E1_NN
-LRB-_-LRB-
YY1_NN
-RRB-_-RRB-
to_TO
a_DT
newly_RB
identified_VBN
element_NN
in_IN
the_DT
first_JJ
exon_NN
of_IN
the_DT
human_JJ
DR_NN
alpha_NN
gene_NN
._.

A_DT
previously_RB
unrecognized_JJ
element_NN
,_,
located_JJ
downstream_JJ
of_IN
the_DT
start_NN
site_NN
of_IN
transcription_NN
in_IN
the_DT
first_JJ
exon_NN
of_IN
the_DT
DR_NN
alpha_NN
gene_NN
,_,
has_VBZ
been_VBN
defined_VBN
that_IN
enhances_VBZ
promoter_NN
activity_NN
up_IN
to_TO
eightfold_JJ
in_IN
a_DT
position-dependent_JJ
manner_NN
._.

Mutations_NNS
in_IN
this_DT
DNA-binding_JJ
site_NN
abolished_VBD
binding_NN
of_IN
a_DT
nuclear_JJ
factor_NN
in_IN
human_JJ
B_NN
cell_NN
nuclear_JJ
extract_NN
and_CC
decreased_VBD
the_DT
activity_NN
of_IN
the_DT
DR_NN
alpha_NN
promoter_NN
to_TO
a_DT
basal_JJ
level_NN
._.

Significant_JJ
sequence_NN
homology_NN
of_IN
this_DT
element_NN
was_VBD
found_VBN
in_IN
the_DT
DNA_NN
of_IN
the_DT
DR_NN
beta_NN
,_,
DP_NN
alpha_NN
and_CC
-_TO
beta_NN
,_,
and_CC
DQ_NN
alpha_NN
genes_NNS
,_,
always_RB
located_JJ
downstream_JJ
of_IN
the_DT
transcriptional_JJ
start_NN
site_NN
._.

The_DT
nuclear_JJ
factor_NN
binds_VBZ
to_TO
the_DT
DR_NN
alpha_NN
and_CC
DP_NN
alpha_NN
element_NN
but_CC
not_RB
to_TO
the_DT
element_NN
in_IN
the_DT
DQ_NN
alpha_NN
gene_NN
._.

It_PRP
was_VBD
identified_VBN
as_IN
NF-E1_NN
-LRB-_-LRB-
YY1_NN
-RRB-_-RRB-
._.

This_DT
protein_NN
,_,
previously_RB
identified_VBN
by_IN
its_PRP$
binding_NN
to_TO
the_DT
Ig_NN
kappa_NN
3_CD
'_POS
enhancer_NN
and_CC
the_DT
Ig_NN
heavy_JJ
chain_NN
mu_NN
E1_NN
site_NN
,_,
thus_RB
also_RB
appears_VBZ
to_TO
be_VB
quite_RB
important_JJ
in_IN
the_DT
regulation_NN
of_IN
MHC_NN
class_NN
II_CD
gene_NN
expression_NN
._.

